Type 1 Renal Tubular Acidosis Secondary to Chronic Kidney Transplant Rejection: A Case Report
DOI:
https://doi.org/10.36557/pbpc.v3i2.227Keywords:
Distal renal tubular acidosis, Kidney transplantation, Chronic rejectionAbstract
Distal renal tubular acidosis (Type 1 RTA) is a rare but significant complication in kidney transplant recipients, particularly when associated with chronic graft rejection. This report describes a 52-year-old male patient with a history of chronic kidney disease and kidney transplantation who developed secondary Type 1 RTA. The patient initially presented with acute pyelonephritis and worsening renal function, later progressing to severe hypokalemia, hypomagnesemia, and hyperuricemia. Laboratory investigations confirmed the diagnosis of Type 1 RTA, characterized by impaired hydrogen ion secretion in the distal tubule, leading to normal anion gap metabolic acidosis and severe electrolyte disturbances. In this context, Type 1 RTA may be linked to the prolonged use of calcineurin inhibitors, such as tacrolimus, which alter the expression and distribution of key acid-base transport proteins, as well as cause functional tubular damage. The management of this condition included electrolyte replacement and adjustments in immunosuppressive therapy, resulting in clinical improvement. This case underscores the importance of early detection and appropriate management of Type 1 RTA to prevent severe complications and preserve graft function in kidney transplant recipients.
References
- Sharma K, Ray A, Chaudhury A. Distal renal tubular acidosis in renal transplant recipients: A case series. Indian J Nephrol. 2017;27(3):212-216. doi:10.4103/ijn.IJN_266_16.
- Jeong S, Lee JH, Kim HS. Chronic rejection of kidney transplant associated with distal renal tubular acidosis: A case report and literature review. BMC Nephrol. 2018;19(1):215. doi:10.1186/s12882-018-1017-9.
- Smith CJ, Smith MC. Renal tubular acidosis: an overview. Ann Clin Biochem. 2014;51(5):303-311. doi:10.1177/0004563213505878.
- Rodrigues BA, Passos AS, Guerreiro R. Renal tubular acidosis: clinical features and pathogenesis. Nefrologia. 2013;33(5):503-512. doi:10.1590/S0101-81752013000500010.
- Myers BD, Balogun RA. Chronic kidney disease and the role of calcineurin inhibitors. Transplant Rev (Orlando). 2017;31(3):134-139. doi:10.1016/j.trre.2017.02.001.
- Haas M, Salih M, Gabutti L, et al. Impact of chronic rejection on renal function and survival of kidney transplant recipients. Nephrol Dial Transplant. 2008;23(7):2190-2198. doi:10.1093/ndt/gfm755.
- Di Iorio B, Volpe M, Ferraro L, et al. Metabolic bone disease after kidney transplantation: current approaches and future perspectives. J Nephrol. 2019;32(3):617-626. doi:10.1007/s40620-019-00646-y.
- Renal tubular acidosis after kidney transplantation—incidence, risk factors and clinical implications. Nephrology Dialysis Transplantation. 2021;36(5):1032-1038. doi:10.1093/ndt/gfab016.
- Norgett EE, Glaudemans B, et al. Distal renal tubular acidosis and severe hypokalemia: A case report and review of the literature. J Med Case Rep. 2020;14:170. doi:10.1186/s13256-020-02517-x.
- Berend K, Levi M. Causes and consequences of metabolic acidosis in patients after kidney transplantation. Kidney Blood Press Res. 2020;45:61-68. doi:10.1159/000506768.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Amanda Silva Medeiros, Antonio Lucas Arruda de Oliveira, Irina Paiva Duarte, Rafael Costa Borges, Natália Silva Carvalho, Victoria Teixeira Leite, Thales Nóbrega Medeiros da Costa, Welmison de Oliveira Dias , Larissa Araújo de Lucena
This work is licensed under a Creative Commons Attribution 4.0 International License.
Você tem o direito de:
- Compartilhar — copiar e redistribuir o material em qualquer suporte ou formato para qualquer fim, mesmo que comercial.
- Adaptar — remixar, transformar, e criar a partir do material para qualquer fim, mesmo que comercial.
- O licenciante não pode revogar estes direitos desde que você respeite os termos da licença.
De acordo com os termos seguintes:
- Atribuição — Você deve dar o crédito apropriado , prover um link para a licença e indicar se mudanças foram feitas . Você deve fazê-lo em qualquer circunstância razoável, mas de nenhuma maneira que sugira que o licenciante apoia você ou o seu uso.
- Sem restrições adicionais — Você não pode aplicar termos jurídicos ou medidas de caráter tecnológico que restrinjam legalmente outros de fazerem algo que a licença permita.